Robarts Research Institute; The University of Western Ontario
London, Ontario, N6A 5B7, Canada
NCT Number: NCT07143747
The goal of this observational study is to better understand how asthma affects the lungs in young adults (ages 17-35) with mild asthma. The main questions it aims to answer are:
* Can advanced imaging detect abnormal airway function in people with mild asthma? * Do changes in ventilation imaging correlate with asthma symptoms or quality of life? Researchers will compare hyperpolarized xenon-129 MRI and Technegas (Tc-99m) imaging to see if these techniques reveal more detailed lung abnormalities than standard lung function tests.
Participants will:
* Complete a single 2-hour visit * Undergo two types of lung imaging: Hyperpolarized xenon-129 MRI (to visualize how air moves in the lungs), Technegas (Tc-99m) imaging (to assess airflow using nuclear medicine) * Perform spirometry and other breathing tests * Answer questionnaires about asthma symptoms and quality of life This study is designed to improve our understanding of subtle changes in lung function that may not be detected by standard tests in people with mild asthma. The findings may lead to better diagnostic tools and more personalized treatment strategies in the future.
Trial opening soon.
Get Notified17 year–35 year
All sexes
Observational
London, Ontario, N6A 5B7, Canada
This is a single centre, study in university-aged participants diagnosed with mild asthma as indicated by a prescription for a short acting bronchodilator for use as needed.
Each participant will participate in one research study visit which includes pre- and post- bronchodilator (BD) spirometry, plethysmography, oscillometry, 129Xe MRI as well as pre-BD ultra-low dose chest CT, Tc99CImaging, blood CBC, sputum induction, as well as completion of the ACQ and AQLQ questionnaires.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Participants eligible for inclusion in this study must meet all of the following criteria:
Exclusion criteria
Participants fulfilling any of the following criteria are not eligible for inclusion in this study:
Inhalation of hyperpolarized 129Xe gas followed by breath-hold MRI for ventilation imaging.
Inhalation of Tc-99m-labeled carbon aerosol (Technegas) followed by SPECT imaging to assess lung ventilation.
Time frame: 1 baseline visit for pre- and post-bronchodilator imaging assessments
Ventilation defects will be assessed using 129Xe MRI and Tc-99m Technegas SPECT imaging. Measurements will include ventilation defect percentage (VDP) and visual scoring to evaluate ventilation abnormalities in participants with mild asthma.
Time frame: 1 baseline visit
In this exploratory study, we hypothesize that there will be significant relationships between ventilation abnormalities and oscillometry as well as FEV1 and asthma control questionnaire (ACQ) score.
Contact information is provided by the study sponsor or research team.
Angela P Wilson, RRT
CONTACT
519-931-5777 ext. 24197
Grace E Parraga, PhD
CONTACT
519-931-5777 ext. 24197
Dr. Grace Parraga
Other
Acronym: PAXT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06618105
Mild Asthma
Multiple Locations, India
View Trial DetailsNCT06433921
Asthma, Bronchial Diseases
Manchester, United Kingdom
View Trial DetailsNCT06563102
Asthma, Bronchial Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT02892344
Mild Asthma
Bulgaria
View Trial Details